Literature DB >> 10027543

3-Nitropropionic acid induces ischemic tolerance in gerbil hippocampus in vivo.

T Sugino1, K Nozaki, Y Takagi, N Hashimoto.   

Abstract

Systemic administration of high dose of 3-nitropropionic acid (3-NP), an irreversible inhibitor of succinate dehydrogenase, causes neurodegeneration within the striatum in vivo. However, it has been reported that pretreatment with low dose of 3-NP may increase tolerance to subsequent hypoxia in hippocampal slices. The present study investigated whether ischemic tolerance can be induced in gerbil hippocampus in vivo by low dose of 3-NP. After pretreatment with 3-NP (single i.p. injection of 3 mg/kg, body weight 2-4 days prior to forebrain ischemia), the number of surviving neurons in CA1 region of hippocampus against succeeding forebrain ischemia was significantly higher than in the ischemic control group. Our results show that chemical preconditioning with low dose of 3-NP induces ischemic tolerance in gerbil hippocampus in vivo.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10027543     DOI: 10.1016/s0304-3940(98)00875-1

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  19 in total

Review 1.  Preconditioning provides neuroprotection in models of CNS disease: paradigms and clinical significance.

Authors:  R Anne Stetler; Rehana K Leak; Yu Gan; Peiying Li; Feng Zhang; Xiaoming Hu; Zheng Jing; Jun Chen; Michael J Zigmond; Yanqin Gao
Journal:  Prog Neurobiol       Date:  2014-01-02       Impact factor: 11.685

2.  Evidence for a role of second pathophysiological stress in prevention of delayed neuronal death in the hippocampal CA1 region.

Authors:  Jozef Burda; Milina Matiasová; Miroslav Gottlieb; Viera Danielisová; Miroslava Némethová; Lidia Garcia; Matilde Salinas; Rastislav Burda
Journal:  Neurochem Res       Date:  2005-11       Impact factor: 3.996

Review 3.  Signaling pathways leading to ischemic mitochondrial neuroprotection.

Authors:  John W Thompson; Srinivasan V Narayanan; Kevin B Koronowski; Kahlilia Morris-Blanco; Kunjan R Dave; Miguel A Perez-Pinzon
Journal:  J Bioenerg Biomembr       Date:  2014-09-28       Impact factor: 2.945

4.  Is there a place for cerebral preconditioning in the clinic?

Authors:  Richard F Keep; Michael M Wang; Jianming Xiang; Ya Hua; Guohua Xi
Journal:  Transl Stroke Res       Date:  2010-01-14       Impact factor: 6.829

Review 5.  Neurotoxins and neurotoxic species implicated in neurodegeneration.

Authors:  Juan Segura Aguilar; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

6.  Mitochondrial toxin 3-nitropropionic acid induces cardiac and neurotoxicity differentially in mice.

Authors:  K L Gabrielson; B A Hogue; V A Bohr; A J Cardounel; W Nakajima; J Kofler; J L Zweier; E R Rodriguez; L J Martin; N C de Souza-Pinto; J Bressler
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

7.  Preconditioning-induced ischemic tolerance: a window into endogenous gearing for cerebroprotection.

Authors:  Aysan Durukan; Turgut Tatlisumak
Journal:  Exp Transl Stroke Med       Date:  2010-01-21

8.  Inhibition of caspase-3 activation and apoptosis is involved in 3-nitropropionic acid-induced ischemic tolerance to transient focal cerebral ischemia in rats.

Authors:  Hong-Can Zhu; Xia-Qun Gao; Ying Xing; Sheng-Gang Sun; Hong-Ge Li; Yun-Fu Wang
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

9.  Mitochondrial complex I inhibition produces selective damage to hippocampal subfield CA1 in organotypic slice cultures.

Authors:  Guangping Xu; Miguel A Perez-Pinzon; Thomas J Sick
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

Review 10.  Global cerebral ischemia: synaptic and cognitive dysfunction.

Authors:  Jake T Neumann; Charles H Cohan; Kunjan R Dave; Clinton B Wright; Miguel A Perez-Pinzon
Journal:  Curr Drug Targets       Date:  2013-01-01       Impact factor: 3.465

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.